AI assistant
Sending…
LOEWS CORP — Director's Dealing 2020
Dec 11, 2020
30284_dirs_2020-12-11_64adab93-4966-49c6-882c-26d440f1dfb8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LOEWS CORP (L)
CIK: 0000060086
Period of Report: 2020-12-10
Reporting Person: TISCH JAMES S (Director, Pres.&Chief Exec. Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-10 | Common Stock | M | 15000 | $39.81 | Acquired | 15000 | Direct |
| 2020-12-10 | Common Stock | M | 15000 | $42.02 | Acquired | 30000 | Direct |
| 2020-12-10 | Common Stock | M | 15000 | $35.04 | Acquired | 45000 | Direct |
| 2020-12-10 | Common Stock | D | 40504 | $43.28 | Disposed | 4496 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-10 | Stock Appreciation Right | $39.81 | M | 15000 | Disposed | 2021-01-11 | Common Stock (15000) | Direct |
| 2020-12-10 | Stock Appreciation Right | $42.02 | M | 15000 | Disposed | 2021-01-11 | Common Stock (15000) | Direct |
| 2020-12-10 | Stock Appreciation Right | $35.04 | M | 15000 | Disposed | 2021-01-11 | Common Stock (15000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 15759280 | Indirect |
Footnotes
F1: The Stock Appreciation Rights became exercisable in four equal installments beginning on January 11, 2012.
F2: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost.
More from LOEWS CORP
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Feb 18
Director's Dealing
2026
Feb 18